Irma Febo to Adolescent
This is a "connection" page, showing publications Irma Febo has written about Adolescent.
Connection Strength
0.176
-
Sheinfil AZ, Giguere R, Dolezal C, Lopez-Rios J, Iribarren S, Brown W, Rael C, Lentz C, Bal?n I, Frasca T, Torres CC, Crespo R, Febo I, Carballo-Di?guez A. Information and Motivation Predict HIV-Serostatus Among a Population of High-Risk Men and Transgender Women Who Have Sex with Men. AIDS Behav. 2020 Oct; 24(10):2863-2871.
Score: 0.023
-
Diaz C, Lin L, Martinez LJ, Eckels KH, Campos M, Jarman RG, De La Barrera R, Lepine E, Toussaint JF, Febo I, Innis BL, Thomas SJ, Schmidt AC. Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico. Am J Trop Med Hyg. 2018 05; 98(5):1435-1443.
Score: 0.019
-
Bauermeister J, Giguere R, Leu CS, Febo I, Cranston R, Mayer K, Carballo-Di?guez A. Interactive Voice Response System: Data Considerations and Lessons Learned During a Rectal Microbicide Placebo Adherence Trial for Young Men Who Have Sex With Men. J Med Internet Res. 2017 06 09; 19(6):e207.
Score: 0.018
-
Giguere R, Frasca T, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Di?guez A. Acceptability of Three Novel HIV Prevention Methods Among Young Male and Transgender Female Sex Workers in Puerto Rico. AIDS Behav. 2016 10; 20(10):2192-2202.
Score: 0.017
-
McGowan I, Cranston RD, Mayer KH, Febo I, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Park SY, Brand RM, Jacobson C, Giguere R, Dolezal C, Frasca T, Leu CS, Schwartz JL, Carballo-Di?guez A. Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women. PLoS One. 2016; 11(6):e0158310.
Score: 0.017
-
Frasca T, Giguere R, Ibitoye M, Dolezal C, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Di?guez A. Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse. Arch Sex Behav. 2017 May; 46(4):1101-1109.
Score: 0.017
-
Silva-Su?rez G, Bastida E, Rabionet SE, Beck-Sagu? C, Febo I, Zorrilla CD. "That's True Love:" Lived Experiences of Puerto Rican Perinatally HIV-Infected Youth within Their Families' Context. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010007.
Score: 0.016
-
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Rivera Torres CM, Chutuape KS, Stines SJ, Straub DM, Peralta L, Febo I, Hightow-Weidman L, Gonin R, Kapogiannis BG, Ellen JM. A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection. J Adolesc Health. 2014 Dec; 55(6):765-73.
Score: 0.015
-
Carballo-Di?guez A, Giguere R, Dolezal C, Bauermeister J, Leu CS, Valladares J, Frasca T, Labbett R, Cranston RD, Febo I, Mayer K, McGowan I. Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research. AIDS Behav. 2014 Sep; 18(9):1726-33.
Score: 0.015
-
McGowan I, Gomez K, Bruder K, Febo I, Chen BA, Richardson BA, Husnik M, Livant E, Price C, Jacobson C. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS. 2011 May 15; 25(8):1057-64.
Score: 0.012
-
Blasini I, Chantry C, Cruz C, Ortiz L, Salabarr?a I, Scalley N, Matos B, Febo I, D?az C. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr. 2004 Jun; 25(3):181-9.
Score: 0.007